pharma · Metastatic Lung Non-Small Cell Carcinoma · COVID-19 · OTLC
Oncotelic Therapeutics
Oncotelic Therapeutics clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Seoul, KR HQ
2020 Founded
14 Employees
Public company Type
OTLC · NYSE Ticker
Company details
- Status
- Public
- HQ
- Seoul, KR
- Founded
- 2020
- Employees
- 14
- Programs
- 4
- Drugs
- 3
- Patents
- 1
Oncotelic Therapeutics projects
0 ClinicalTrials.gov programs sponsored by Oncotelic Therapeutics.
Oncotelic Therapeutics has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Oncotelic Therapeutics have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.